MedTrace Logo

Study of Anti-Mesothelin Car NK Cells in Epithelial Ovarian Cancer

NCT03692637 · Status: UNKNOWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2019-01-31

No results posted yet for this study

Summary

This is a single centre、single arm、open-label，to investigate the safety and efficacy of anti-Mesothelin Car NK Cells With Epithelial ovarian cancer

Conditions

  • Epithelial Ovarian Cancer

Interventions

BIOLOGICAL

anti-Mesothelin Car NK Cells

anti-Mesothelin Car NK Cells injection

Sponsors & Collaborators

  • Allife Medical Science and Technology Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-31
Primary Completion
2020-11-30
Completion
2021-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03692637 on ClinicalTrials.gov